Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Erschienen in:
Koexistenz von Depression, Angst, traumatischem Stress und körperlicher Krankheit – allgemeine Positionen Kapitel lesen Erstes Kapitel lesen

2022 | OriginalPaper | Buchkapitel

4. Diabetes mellitus

verfasst von : Hans-Peter Kapfhammer

Erschienen in: Depression, Angst, traumatischer Stress und internistische Erkrankungen

Verlag: Springer Berlin Heidelberg

Einloggen, um Zugang zu erhalten

Zusammenfassung

Diabetes mellitus zählt zu den Krankheitsgruppen mit den höchsten Risiken einer vorzeitigen Mortalität. Vor allem für den Typ-2 Diabetes ist weltweit ein Anstieg der Inzidenzraten zu beobachten. Ätiopathogenese und Pathophysiologie von Typ-1 und Typ-2 Diabetes unterscheiden sich wesentlich. Beide teilen sich aber gemeinsame Spätkomplikationen im Krankheitsverlauf. Koexistente affektive und Stress-bezogene Störungen sind bei beiden Formen des Diabetes mellitus erhöht und mit je bedeutsamen negativen Effekten auf den Krankheitsverlauf assoziiert. Vorausgehende psychische Störungen und Stressfaktoren nehmen einen differentiellen Einfluss auf das jeweilige somatische Erkrankungsrisiko. Zu den Interaktionen zwischen psychischer und somatischer Komorbidität existieren detaillierte biopsychosoziale Erkenntnisse. Trotz einiger ermutigender Resultate erweisen sich sowohl Psychotherapien als auch Pharmakotherapien in der Behandlung von koexistenten affektiven und Stress-bezogenen Störungen bei Diabetes mellitus als weniger wirksam als ohne diesen somatische Krankheitskontext. Um den biologischen Krankheitsverlauf nachhaltig zu beeinflussen, genügen beide psychologischen und medikamentösen Verfahren je alleine nicht. Eine Änderung langfristig etablierter ungesunder Verhaltensweisen ist am ehesten durch gezielte gesundheitspsychologische Ansätze im Rahmen integrativer Versorgungsmodelle zu erreichen.
Literatur
Abraham S, Shah NG, Diez Roux A et al (2015) Trait anger but not anxiety predicts incident type 2 diabetes: the multi-ethnic study of atherosclerosis (MESA). Psychoneuroendocrinology 60:105–113CrossRef
Abrahamian H, Hofmann P, Kinzl J, Toplak H (2012) Diabetes mellitus and comorbid depression: improvement of both diseases with milnacipran. A replication study (results of the Austrian Major Depression Diabetes Mellitus study group). Neuropsychiatr Dis Treat 8:355–360CrossRef
Abrahamian H, Hofmann P, Prager R, Toplak H (2009) Diabetes mellitus and co-morbid depression: treatment with milnacipran results in significant improvement of both diseases (results from the Austrian MDDM study group). Neuropsychiatr Dis Treat 5:261–266CrossRef
Aikens JE, Perkins DW, Lipton B, Piette JD (2009) Longitudinal analysis of depressive symptoms and glycemic control in type 2 diabetes. Diabetes Care 32:1177–1181CrossRef
Albus C, Petrak F (2021) Psychodiabetologie. Psychother Psychosom Med Psychol 71:141–157CrossRef
Al Hayek AA, Robert AA, Braham RB et al (2015) Predictive risk factors for fear of hypoglycemia and anxiety-related emotional disorders among adolescents with type 1 diabetes. Med Princ Pract 24:222–230CrossRef
Ali MK, Chwastiak L, Poongothai S, et al INDEPENDENT Study Group (2020) Effect of a collaborative care model on depressive symptoms and glycated hemoglobin, blood pressure, and serum cholesterol among patients with depression and diabetes in india: The INDEPENDENT Randomized Clinical Trial. JAMA 324:651–662
Ali S, Stone MA, Peters JL, Davies MJ, Khunti K (2006) The prevalence of co-morbid depression in adults with Type 2 diabetes: a systematic review and meta-analysis. Diabet Med 23:1165–1173CrossRef
Alzoubi A, Abunaser R, Khassawneh A et al (2018) The bidirectional relationship between diabetes and depression: a literature review. Korean J Fam Med 39:137–146CrossRef
Anagnostis P, Athyros VG, Tziomalos K et al (2009) Clinical review. The pathogenetic role of cortisol in the metabolic syndrome: a hypothesis. Clin Endocrinol Metab 94:2692–2701CrossRef
Anderson RJ, Freedland KE, Clouse RE, Lustman PJ (2001) The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care 24:1069–1078CrossRef
Apovian CM, Aronne L, Rubino D, Still C et al (2013) A randomized, phase 3 trial of naltrexone SR/bupropion SR on weight and obesity-related risk factors (COR-II). Obesity (Silver Spring) 21:935–943CrossRef
Aquino JA, Baldoni NR, Flôr CR et al (2018) Effectiveness of individual strategies for the empowerment of patients with diabetes mellitus: a systematic review with meta-analysis. Prim Care Diabetes 12:97–110CrossRef
Arafa A, Dong JY (2019) Gestational diabetes and risk of postpartum depressive symptoms: a meta-analysis of cohort studies. J Affect Disord 253:312–316CrossRef
Armstrong B, Mackey ER, Streisand R (2011) Parenting behavior, child functioning, and health behaviors in preadolescents with type 1 diabetes. J Pediatr Psychol 36:1052–1061CrossRef
Asuzu CC, Walker RJ, Williams JS, Egede LE (2017) Pathways for the relationship between diabetes distress, depression, fatalism and glycemic control in adults with type 2 diabetes. J Diabetes Complications 31:169–174CrossRef
Atkinson MA, Eisenbarth GS, Michels AW (2014) Type 1 diabetes. Lancet 383(9911):69–82CrossRef
Atlantis E, Vogelzangs N, Cashman K, Penninx BJ (2012) Common mental disorders associated with 2-year diabetes incidence: the Netherlands study of depression and anxiety (NESDA). J Affect Disord 142(suppl):S30-35CrossRef
Barnard K, Peveler RC, Holt RI (2013) Antidepressant medication as a risk factor for type 2 diabetes and impaired glucose regulation: systematic review. Diabetes Care 36:3337–3345CrossRef
Barnard-Kelly KD, Naranjo D, Majidi S et al (2020) Suicide and self-inflicted injury in diabetes: a balancing act. J Diabetes Sci Technol 14:1010–1016CrossRef
Bartoli F, Carrà G, Crocamo C et al (2013) Metabolic syndrome in people suffering from posttraumatic stress disorder: a systematic review and meta-analysis. Metab Syndr Relat Disord 11:301–308CrossRef
Bartoli F, Crocamo C, Alamia A et al (2015) Posttraumatic stress disorder and risk of obesity: systematic review and meta-analysis. J Clin Psychiatry 76:e1253–e1261CrossRef
Basu A, McLaughlin KA, Misra S, Koenen KC (2017) Childhood maltreatment and health impact: the examples of cardiovascular disease and type 2 diabetes mellitus in adults. Clin Psychol (New York) 24:125–139
Baucom KJW, Turner SL, Tracy EL et al (2018) Depressive symptoms and diabetes management from late adolescence to emerging adulthood. Health Psychol 37:716–724CrossRef
Baumeister H, Hutter N, Bengel J (2014) Psychological and pharmacological interventions for depression in patients with diabetes mellitus: an abridged cochrane review. Diabet Med 31:773–786CrossRef
Beka Q, Bowker SL, Savu A et al (2018) History of mood or anxiety disorders and risk of gestational diabetes mellitus in a population-based cohort. Diabet Med 35:147–151CrossRef
Benkert O, Hippius H (2021) Kompendium der psychiatrischen Pharmakotherapie, 13. Aufl. Springer, Berlin/HeidelbergCrossRef
Bergantin LB (2019) Debating the “bidirectional link” between diabetes and depression through the Ca2+/cAMP signalling: off-label effects of Ca2+ channel blockers. Pharmacol Res 141:298–302CrossRef
Bet PM, Hugtenburg JG, Penninx BWJH, Hoogendijk WJG (2013) Side effects of antidepressants during long-term use in a naturalistic setting. Eur Neuropsychopharmacol 23:1443–1451CrossRef
Boden MT (2018) Prevalence of mental disorders and related functioning and treatment engagement among people with diabetes. J Psychosom Res 106:62–69CrossRef
Bogner HR, Morates KH, Post EP, Bruce ML (2007) Diabetes, depression, and death: a randomized controlled trial of a depression treatment program for older adults based in primary care (PROSPECT). Diabetes Care 30:3005–3010CrossRef
Boyko EJ, Seelig AD, Jacobson IG et al (2013) Sleep characteristics, mental health, and diabetes risk: a prospective study of U.S. military service members in the Millennium Cohort study. Diabetes Care 36:3154–3161CrossRef
Brewerton TD (2017) Food addiction as a proxy for eating disorder and obesity severity, trauma history, PTSD symptoms, and comorbidity. Eat Weight Disord 22:241–247CrossRef
Broadley MM, White MJ, Andrew B (2018) Executive function is associated with diabetes-specific disordered eating in young adults with type 1 diabetes. J Psychosom Res 111:1–12CrossRef
Buchberger B, Huppertz H, Krabbe L et al (2016) Symptoms of depression and anxiety in youth with type 1 diabetes: a systematic review and meta-analysis. Psychoneuroendocrinology 70:70–84CrossRef
Bundesministerium Frauen Gesundheit (2017) Österreichischer Diabetesbericht 2017. BMGF, Wien
Butnoriene J, Bunevicius A, Norkus A, Bunevicius R (2014) Depression but not anxiety is associated with metabolic syndrome in primary care based community sample. Psychoneuroendocrinology 40:269–276CrossRef
Butwicka A, Frisén L, Almqvist C, Zethelius B, Lichtenstein P (2015) Risks of psychiatric disorders and suicide attempts in children and adolescents with type 1 diabetes: a population-based cohort study. Diabetes Care 38:453–459CrossRef
Callesen NF, Secher AL, Cramon P et al (2015) Mental health in early pregnancy is associated with pregnancy outcome in women with pregestational diabetes. Diabet Med 32:1484–1491CrossRef
Cannon A, Handelsman Y, Heile M, Shannon (2018) Burden of illness in type 2 diabetes mellitus. J Manag Care Spec Pharm 24 (9-a Suppl):S5–S13
Carnagarin R, Lambert GW, Kiuchi MG et al (2019) Effects of sympathetic modulation in metabolic disease. Ann N Y Acad Sci 1454:80–89CrossRef
Caroleo M, Carbone EA, Primerano A et al (2019) The role of hormonal, metabolic and inflammatory biomarkers on sleep and appetite in drug free patients with major depression: a systematic review. J Affect Disord 250:249–259CrossRef
Castellano-Guerrero AM, Guerrero R, Relimpio F et al (2018) Prevalence and predictors of depression and anxiety in adult patients with type 1 diabetes in tertiary care setting. Acta Diabetol 55:943–953CrossRef
Cecilia-Costa R, Volkening LK, Laffel LM (2019) Factors associated with disordered eating behaviours in adolescents with Type 1 diabetes. Diabet Med 36:1020–1027CrossRef
Celik A, Forde R, Racaru S et al (2022) The impact of type 2 diabetes on women’s health and well-being during their reproductive years: a mixed-methods systematic review. Curr Diabetes Rev 18:31–51CrossRef
Chaudhary R, Kumar P, Chopra A et al (2017) Comparative study of psychiatric manifestations among type I and type II diabetic patients. Indian J Psychol Med 39:342–346CrossRef
Che T, Teng X, Huang Q et al (2018) Agomelatine versus fluoxetine in glycemic control and treating depressive and anxiety symptoms in type 2 diabetes mellitus subjects: a single-blind randomized controlled trial. Neuropsychiatr Dis Treat 14:1527–1533CrossRef
Chevinsky JD, Wadden TA, Chao AM (2020) Binge eating disorder in patients with type 2 diabetes: diagnostic and management challenges. Diabetes Metab Syndr Obes 13:1117–1131CrossRef
Chida Y, Hamer M (2008) An association of adverse psychosocial factors with diabetes mellitus: a meta-analytic review of longitudinal cohort studies. Diabetologia 51:2168–2178CrossRef
Chien IC, Lin CH (2016) Increased risk of diabetes in patients with anxiety disorders: a population-based study. J Psychosom Res 86:47–52CrossRef
Chiu CJ, Du YF (2019) Longitudinal investigation of the reciprocal relationship between depressive symptoms and glycemic control: the moderation effects of sex and perceived support. J Diabetes Investig 10:801–808CrossRef
Christie D, Thompson R, Sawtell M et al (2014) Structured, intensive education maximising engagement, motivation and long-term change for children and young people with diabetes: a cluster randomised controlled trial with integral process and economic evaluation – the CASCADE study. Health Technol Assess 18:1–202CrossRef
Chrousos GP (2009) Stress and disorders of the stress system. Nat Rev Endocrinol 5:374–381CrossRef
Chuang JC, Krishnan V, Yu HG et al (2010) A beta3-adrenergic-leptin-melanocortin circuit regulates behavioral and metabolic changes induced by chronic stress. Biol Psychiatry 67:1075–1082CrossRef
Ciechanowski P, Russo J, Katon W et al (2006) Where is the patient? The association of psychosocial factors and missed primary care appointments in patients with diabetes. Gen Hosp Psychiatry 28:9–17CrossRef
Compas BE, Jaser SS, Bettis AH et al (2017) Coping, emotion regulation, and psychopathology in childhood and adolescence: a meta-analysis and narrative review. Psychol Bull 143:939–991CrossRef
Cooper MN, Lin A, Alvares GA et al (2017) Psychiatric disorders during early adulthood in those with childhood onset type 1 diabetes: rates and clinical risk factors from population-based follow-up. Pediatr Diabetes 18:599–606CrossRef
Cosgrove M (2004) Do stressful life events cause type 1 diabetes? Occup Med (Lond) 54:250–254CrossRef
Cosgrove MP, Sargeant LA, Caleyachetty R, Griffin SJ (2012) Work-related stress and Type 2 diabetes: systematic review and meta-analysis. Occup Med (London) 62:167–173CrossRef
Cosgrove MP, Sargeant LA, Griffin SJ (2008) Does depression increase the risk of developing type 2 diabetes? Occup Med (Lond) 58:7–14CrossRef
Cukierman-Yaffe T, Gerstein HC, Anderson C, et al; ONTARGET/TRANSCEND Investigators (2009) Glucose intolerance and diabetes as risk factors for cognitive impairment in people at high cardiovascular risk: results from the ONTARGET/TRANSCEND research programme. Diabetes Res Clin Pract 83:387–393
Darwish L, Beroncal E, Sison MV, Swardfager W (2018)Depression in people with type 2 diabetes: current perspectives. Diabetes Metab Syndr Obes 11:333–343
Davis C (2017) A commentary on the associations among ‘food addiction’, binge eating disorder, and obesity: overlapping conditions with idiosyncratic clinical features. Appetite 115:3–8CrossRef
De Groot M (2020) 50 years of behavioral science in diabetes: a 2020 vision of the future. Diabetes Spectr 34:76–84CrossRef
de Groot M, Anderson R, Freedland KE, Clouse RE, Lustman PJ (2001) Association of depression and diabetes complications: a meta-analysis. Psychosom Med 63:619–630CrossRef
de Groot M, Golden SH, Wagner J (2016) Psychological conditions in adults with diabetes. Am Psychol 71:552–562CrossRef
de Groot M, Shubrook JH, Hornsby WG Jr et al (2019) Program ACTIVE II: outcomes from a randomized, multistate community-based depression treatment for rural and urban adults with type 2 diabetes. Diabetes Care 42:1185–1193CrossRef
de Jonge P, Alonso J, Stein DJ et al (2014) Associations between DSM-IV mental disorders and diabetes mellitus: a role for impulse control disorders and depression. Diabetologia 57:699–709CrossRef
Demakakos P, Zaninotto P, Nouwen A (2014) Is the association between depressive symptoms and glucose metabolism bidirectional? Evidence from the english longitudinal study of ageing. Psychosom Med 76:555–561CrossRef
Den Heijer T, Vermeer SE, van Dijk EJ et al (2003) Type 2 diabetes and atrophy of medial temporal lobe structures on brain MRI. Diabetologia 46:1604–1610CrossRef
Deschênes SS, Burns RJ, Pouwer F, Schmitz N (2017) Diabetes complications and depressive symptoms: prospective results from the Montreal diabetes health and well-being study. Psychosom Med 79:603–612CrossRef
Deschênes SS, Burns RJ, Schmitz N (2015) Associations between diabetes, major depressive disorder and generalized anxiety disorder comorbidity, and disability: findings from the 2012 Canadian community health survey – mental health (CCHS-MH). J Psychosom Res 78:137–142CrossRef
Deschênes SS, Burns RJ, Schmitz N (2018a) Comorbid depressive and anxiety symptoms and the risk of type 2 diabetes: findings from the lifelines cohort study. J Affect Disord 238:24–31CrossRef
Deschênes SS, Burns RJ, Schmitz N (2018b) Trajectories of anxiety symptoms and associations with incident cardiovascular disease in adults with type 2 diabetes. J Psychosom Res 104:95–100CrossRef
Detka J, Kurek A, Basta-Kaim A et al (2013) Neuroendocrine link between stress, depression and diabetes. Pharmacol Rep 65:1591–1600CrossRef
Deuschle M (2013) Effects of antidepressants of glucose metabolism and diabetes mellitus type 2 in adults. Curr Opin Psychiatry 26:60–65CrossRef
Deuschle M, Schweiger U (2012) Depression und diabetes mellitus Type 2. Nervenarzt 83:1410–1422CrossRef
Deutsche Diabetes Gesellschaft (DDG) und diabetesDE – Deutsche Diabetes-Hilfe (2018) Deutscher Gesundheitsbericht Diabetes 2018. Kirchheim + Co GmbH, Mainz
Dhabhar FS (2014) Effects of stress on immune function: the good, the bad, and the beautiful. Immunol Res 58:193–210CrossRef
Dismuke CE, Hernandez-Tejada MA, Egede LE (2014) Relationship of serious psychological distress to quality of life in adults with diabetes. Int J Psychiatry Med 48:135–146CrossRef
Dorsch VM, Rohde A (2017) Frauenspezifische psychische Störungen in der Psychiatrie. In: Möller HJ, Laux G, Kapfhammer HP (Hrsg) Psychiatrie, Psychosomatik und Psychotherapie. 5. Aufl. Springer Verlag GmbH Deutschland, Bd. 4, 2809–2828
Drevets WC, Price JL, Furey ML (2008) Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression. Brain Struct Funct 213:93–118
Due-Christensen M, Zoffmann V, Willaing I et al (2018) The process of adaptation following a new diagnosis of type 1 diabetes in adulthood: a meta-synthesis. Qual Health Res 28:245–258CrossRef
Duelli R, Kuschinsky W (2001) Brain glucose transporters: relationship to local energy demand. News Physiol Sci 16:71–76
Dybdal D, Tolstrup JS, Sildorf SM et al (2018) Increasing risk of psychiatric morbidity after childhood onset type 1 diabetes: a population-based cohort study. Diabetologia 61:831–838CrossRef
Eaton WW, Armenian H, Gallo J, Pratt L, Ford DE (1996) Depression and risk for onset of type II diabetes: a prospective population-based study. Diabetes Care 19:1097–1102CrossRef
Echeverry D, Duran P, Bonds C et al (2009) Effect of pharmacological treatment of depression on A1C and quality of life in low-income Hispanics and African Americans with diabetes: a randomized, double-blind, placebo-controlled trial. Diabetes Care 32:2156–2160CrossRef
Edwards LE, Mezuk B (2012) Anxiety and risk of type 2 diabetes: evidence from the baltimore epidemiologic catchment area study. J Psychosom Res 73:418–423CrossRef
Egan AM, Dunne FP, Lydon K et al (2017) Diabetes in pregnancy: worse medical outcomes in type 1 diabetes but worse psychological outcomes in gestational diabetes. QJM 110:721–727CrossRef
Egede LE (2004) Diabetes, major depression, and functional disability among U.S. adults. Diabetes Care 27:421–428CrossRef
Egede LE, Nietert PJ, Zhent D (2005) Depression and all-cause and coronary heart disease mortality among adults with and without diabetes. Diabetes Care 28:1339–1345CrossRef
Ehrenthal JC, Düx A, Baie L, Burgmer M (2019)Levels of personality functioning and not depression predict decline of plasma glucose concentration in patients with type 2 diabetes mellitus. Diabetes Res Clin Pract 151:106–113
Ehrmann D, Kulzer B, Haak T, Hermanns N (2015) Longitudinal relationship of diabetes-related distress and depressive symptoms: analysing incidence and persistence. Diabet Med 32:1264–1271CrossRef
El-Gabalawy R, Blaney C, Tsai J, Sumner JA, Pietrzak R (2018) Physical health conditions associated with full and subthreshold PTSD in U.S. military veterans: results from the national health and resilience in veterans study. J Affect Disord 227:849–853CrossRef
Elgendy R, Deschênes SS, Burns RJ, Schmitz N (2018) Do mental disorders moderate the association between diabetes status and alcohol consumption? Psychol Health Med 23:277–284CrossRef
Ell K, Katon W, Xie B et al (2010) Collaborative care management of major depression among low-income, predominantly Hispanic subjects with diabetes: a randomized controlled trial. Diabetes Care 33:706–713CrossRef
Ellis DA, Carcone AI, Slatcher R et al (2019) Efficacy of mindfulness-based stress reduction in emerging adults with poorly controlled, type 1 diabetes: a pilot randomized controlled trial. Pediatr Diabetes 20:226–234
Endo S, Saisho Y, Miyakoshi K, et al (2018) Association of maternal factors with perinatal complications in pregnancies complicated with diabetes: a single-center retrospective analysis. J Clin Med 7(1). pii:E5. https://​doi.​org/​10.​3390/​jcm7010005
Engum A (2007) The role of depression and anxiety in onset of diabetes in a large population-based study. J Psychosom Res 62:31–38CrossRef
Ervasti J, Kivimäki M, Dray-Spira R et al (2016) Psychosocial factors associated with work disability in men and women with diabetes: a pooled analysis of three occupational cohort studies. Diabet Med 33:208–217CrossRef
Faresjö M (2015) The link between psychological stress and autoimmune response in children. Crit Rev Immunol 35:117–134CrossRef
Farooqi A, Gillies C, Sathanapally H et al (2022) A systematic review and meta-analysis to compare the prevalence of depression between people with and without Type 1 and Type 2 diabetes. Prim Care Diabetes 16:1–10CrossRef
Farr OM, Ko BJ, Ke J et al (2015) Posttraumatic stress disorder, alone or additively with early life adversity, is associated with obesity and cardiometabolic risk. Nutr Metab Cardiovasc Dis 25:479–488CrossRef
Farvid MS, Qi L, Hu FB et al (2014) Phobic anxiety symptom scores and incidence of type 2 diabetes in US men and women. Brain Behav Immun 36:176–182CrossRef
Feig DS, Donovan LE, Corcoy R et al (2017) Continuous glucose monitoring in pregnant women with type 1 diabetes (CONCEPTT): a multicentre international randomised controlled trial. Lancet 390(10110):2347–2359CrossRef
Fisher L, Mullan JT, Arean P, Glasgow RE, Hessler D, Masharani U (2010) Diabetes distress but not clinical depression or depressive symptoms is associated with glycemic control in both cross-sectional and longitudinal analyses. Diabetes Care 33:23–28CrossRef
Fisher L, Polonsky WH, Hessler D (2019) Addressing diabetes distress in clinical care: a practical guide. Diabet Med 36:803–812
Flatt JD, Gilsanz P, Quesenberry CP Jr et al (2018) Post-traumatic stress disorder and risk of dementia among members of a health care delivery system. Alzheimers Dement 14:28–34CrossRef
Fletcher PC, Kenny PJ (2018) Food addiction: a valid concept? Neuropsychopharmacology 43:2506–2513CrossRef
Fonagy P, Moran GS, Lindsay MK, Kurtz AB, Brown R (1987) Psychological adjustment and diabetic control. Arch Dis Child 62:1009–1013CrossRef
Frau F, Crowther D, Ruetten H, Allebrandt KV (2017) Type-2 diabetes-associated variants with cross-trait relevance: post-GWAs strategies for biological function interpretation. Mol Genet Metab 121:43–50CrossRef
Fritschi C, Quinn L (2010) Fatigue in patients with diabetes: a review. J Psychosom Res 69:33–41CrossRef
Gagnon C, Aimé A, Bélanger C (2017) Predictors of comorbid eating disorders and diabetes in people with type 1 and type 2 diabetes. Can J Diabetes 41:52–57CrossRef
Gagnon C, Aimé A, Bélanger C, Markowitz JT (2012) Comorbid diabetes and eating disorders in adult patients: assessment and considerations for treatment. Diabetes Educ 38:537–542CrossRef
Gariepy G, Nitka D, Schmitz N (2010) The association between obesity and anxiety disorders in the population: a systematic review and meta-analysis. Int J Obes (Lond) 34:407–419CrossRef
Gibson-Smith D, Bot M, Milaneschi Y et al (2016) Major depressive disorder, antidepressant use, and subsequent 2-year weight change patterns in the Netherlands study of depression and anxiety. J Clin Psychiatry 77:e144-151CrossRef
Gilsanz P, Karter AJ, Beeri MS et al (2018) The bidirectional association between depression and severe hypoglycemic and hyperglycemic events in type 1 diabetes. Diabetes Care 41:446–452CrossRef
Graham EA, Deschênes SS, Khalil MN et al (2020) Measures of depression and risk of type 2 diabetes: a systematic review and meta-analysis. J Affect Disord 265:224–232CrossRef
Goffrier B, Schulz M, Bätzing-Feigenbaum J (2017) Administrative Prävalenzen und Inzidenzen des Diabetes mellitus von 2009 bis 2015. Zentralinstitut für die kassenärztliche Versorgung in Deutschland (Zi). Versorgungsatlas-Bericht Nr. 17/03. Berlin. https://​doi.​org/​10.​20364/​VA-17.​03
Gonzalez JS, Tanenbaum ML, Commissariat PV (2016) Psychosocial factors in medication adherence and diabetes self-management: implications for research and practice. Am Psychol 71:539–551CrossRef
Gragnoli C (2014) Hypothesis of the neuroendocrine cortisol pathway gene role in the comorbidity of depression, type 2 diabetes, and metabolic syndrome. Appl Clin Genet 7:43–53CrossRef
Greenway FL, Fujioka K, Plodkowski RA et al (2010) Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet 376(9741):595–605CrossRef
Greig SL, Keating GM (2015) Naltrexone ER/Bupropion ER: a review in obesity management. Drugs 75:1269–1280CrossRef
Grigsby AB, Anderson RJ, Freedland KE, Clouse RE, Lustman PJ (2002) Prevalence of anxiety in adults with diabetes: a systematic review. J Psychosom Res 53:1053–1060CrossRef
Guerrero Pérez F, Sánchez-González J, Sánchez I et al (2019) Food addiction and preoperative weight loss achievement in patients seeking bariatric surgery. Eur Eat Disord Rev 26:645–656CrossRef
Gulley LD, Shomaker LB, Kelly NR et al (2019) Indirect effects of a cognitive-behavioral intervention on adolescent weight and insulin resistance through decreasing depression in a randomized controlled trial. J Pediatr Psychol 44:1163–1173CrossRef
Gulseren L, Gulseren S, Hekimsoy Z et al (2005) Comparison of fluoxetine and paroxetine in type II diabetes mellitus patients. Arch Med Res 36:159–165CrossRef
Hackett RA, Steptoe A (2017) Type 2 diabetes mellitus and psychological stress - a modifiable risk factor. Nat Rev Endocrinol 13:547–560
Hägglöf B, Blom L, Dahlquist G, Lönnberg G, Sahlin B (1991) The Swedish childhood diabetes study: indications of severe psychological stress as a risk factor for type 1 (insulin-dependent) diabetes mellitus in childhood. Diabetologia 34:579–583CrossRef
Hamer JA, Testani D, Mansur RB et al (2019) Brain insulin resistance: a treatment target for cognitive impairment and anhedonia in depression. Exp Neurol 315:1–8CrossRef
Handwerger K (2009) Differential patterns of HPA activity and reactivity in adult posttraumatic stress disorder and major depressive disorder. Harv Rev Psychiatry 17:184–205CrossRef
Haroon E, Raison CL, Miller AH (2012) Psychoneuroimmunology meets neuropsychopharmacology: translational implications of the impact of inflammation on behavior. Neuropsychopharmacology 37:137–162CrossRef
Hay JW, Katon WJ, Ell K et al (2012) Cost-effectiveness analysis of collaborative care management of major depression among low-income, predominantly Hispanics with diabetes. Value Health 15:249–254CrossRef
Helgeson VS, Orchard TJ, Seltman H et al (2019) Psychosocial predictors of diabetes risk factors and complications: An 11-year follow-up. Health Psychol 38:567–576CrossRef
Hermanns N, Kulzer B, Krichbaum M et al (2005) Affective and anxiety disorders in a German sample of diabetic patients: prevalence, comorbidity and risk factors. Diabet Med 22:293–300CrossRef
Hermanns N, Schmitt A, Gahr A et al (2015) The effect of a diabetes-specific cognitive behavioral treatment program (DIAMOS) for patients with diabetes and subclinical depression: results of a randomized controlled trial. Diabetes Care 38:551–560CrossRef
Herpertz S, de Zwaan M, Zipfel S (Hrsg) (2015) Handbuch Essstörungen und Adipositas, 2. Aufl. Springer, Berlin
Hinkle SN, Buck Louis GM, Rawal S et al (2016) A longitudinal study of depression and gestational diabetes in pregnancy and the postpartum period. Diabetologia 59:2594–2602CrossRef
Ho N, Sommers MS, Lucki I (2013) Effects of diabetes on hippocampal neurogenesis: links to cognition and depression. Neurosci Biobehav Rev 37:1346–1362CrossRef
Hollander P, Gupta AK, Plodkowski R et al (2013) Effects of naltrexone sustained-release/bupropion sustained-release combination therapy on body weight and glycemic parameters in overweight and obese patients with type 2 diabetes. Diabetes Care 36:4022–4029CrossRef
Hood MM, Reutrakul S, Crowley SJ (2014) Night eating in patients with type 2 diabetes. Associations with glycemic control, eating patterns, sleep, and mood. Appetite 79:91–96CrossRef
Huang CJ, Hsieh HM, Chiu HC et al (2017) Impact of anxiety disorders on mortality for persons with diabetes: a national population-based cohort study. Psychosomatics 58:266–273CrossRef
Huang CY, Lai HL, Chen CI et al (2016) Effects of motivational enhancement therapy plus cognitive behaviour therapy on depressive symptoms and health-related quality of life in adults with type II diabetes mellitus: a randomised controlled trial. Qual Life Res 25:1275–1283CrossRef
Huang H, Yan P, Shan Z et al (2015) Adverse childhood experiences and risk of type 2 diabetes: a systematic review and meta-analysis. Metabolism 64:1408–1418CrossRef
Hughes K, Bellis MA, Hardcastle KA et al (2017) The effect of multiple adverse childhood experiences on health: a systematic review and meta-analysis. Lancet Pub Health 2:e356–e366CrossRef
Hunter CM (2016) Understanding diabetes and the role of psychology in its prevention and treatment. Am Psychol 7:515–525CrossRef
Hussain S, Habib A, Singh A, Akhtar M, Najmi AK (2018) Prevalence of depression among type 2 diabetes mellitus patients in India: a meta-analysis. Psychiatry Res 270:264–273CrossRef
Indelicato L, Dauriz M, Santi L et al (2017) Psychological distress, self-efficacy and glycemic control in type 2 diabetes. Nutr Metab Cardiovasc Dis 27:300–306CrossRef
Ismail K, Stahl D, Bayley A et al (2019) Enhanced motivational interviewing for reducing weight and increasing physical activity in adults with high cardiovascular risk: the MOVE IT three-arm RCT. Health Technol Assess 23:1–144CrossRef
Jeeva F, Dickens C, Coventry P et al (2013) Is treatment of depression cost-effective in people with diabetes? A systematic review of the economic evidence. Int J Technol Assess Health Care 29:384–391CrossRef
Jeong M, Reifsnider E (2018) Associations of diabetes-related distress and depressive symptoms with glycemic control in Korean Americans with type 2 diabetes. Diabetes Educ 44:531–540CrossRef
Jia X, Yang Y, Chen Y et al (2019a) Multivariate analysis of genome-wide data to identify potential pleiotropic genes for type 2 diabetes, obesity and coronary artery disease using MetaCCA. Int J Cardiol 283:144–150CrossRef
Jia X, Yang Y, Chen Y et al (2019b) Multivariate analysis of genome-wide data to identify potential pleiotropic genes for five major psychiatric disorders using MetaCCA. J Affect Disord 242:234–243CrossRef
Johnson JA, Lier DA, Soprovich A et al (2016) Cost-effectiveness evaluation of collaborative care for diabetes and depression in primary care. Am J Prev Med 51:e13–e20CrossRef
Johnson JA, Al Sayah F, Wozniak L et al (2014) Collaborative care versus screening and follow-up for patients with diabetes and depressive symptoms: results of a primary care-based comparative effectiveness trial. Diabetes Care 37:3220–3226CrossRef
Johnson LCM, Chwastiak L, Poongothai S et al (2020) Adaptations and patient responses to behavioral intervention components in a depression-focused chronic disease care model implemented in India. Transl Behav Med 10:35–45CrossRef
Jokela M, Hamer M, Singh-Manoux A, Batty GD, Kivimäki M (2014) Association of metabolically healthy obesity with depressive symptoms: pooled analysis of eight studies. Mol Psychiatry 19:910–914CrossRef
Jones A, Gladstone BP, Lübeck M et al (2014) Motivational interventions in the management of HbA1c levels: a systematic review and meta-analysis. Prim Care Diabetes 8:91–100CrossRef
Joseph JJ, Golden SH (2017) Cortisol dysregulation: the bidirectional link between stress, depression, and type 2 diabetes mellitus. Ann N Y Acad Sci 1391:20–34CrossRef
Jurgen B, Baker CN, Kamps JL et al (2020) Associations between depressive Symptoms, fear of hypoglycemia, adherence to management behaviors and metabolic control in children and adolescents with type 1 diabetes. J Clin Psychol Med Settings 27:385–395CrossRef
Kampling H, Mittag O, Herpertz S et al (2018) Can trajectories of glycemic control be predicted by depression, anxiety, or diabetes-related distress in a prospective cohort of adults with newly diagnosed type 1 diabetes? Results of a five-year follow-up from the German multicenter diabetes cohort study (GMDC-Study). Diabetes Res Clin Pract 141:106–117CrossRef
Kan C, Silva N, Golden SH et al (2013) A systematic review and meta-analysis of the association between depression and insulin resistance. Diabetes Care 36:480–489CrossRef
Kang R, He Y, Yan Y et al (2015) Comparison of paroxetine and agomelatine in depressed type 2 diabetes mellitus patients: a double-blind, randomized, clinical trial. Neuropsychiatr Dis Treat 11:1307–1311
Kapfhammer HP (1993) Zur psychosozialen Entwicklung im jungen Erwachsenenalter: entwicklungspsychologische Charakterisierung eines bedeutsamen Abschnitts im Lebenszyklus. Fortschr Neurol Psychiatr 61:338–353CrossRef
Kapfhammer HP (2005) Spätadoleszenz und junges Erwachsenenalter – ätiopathogenetische Bedeutung für schizophrene Psychosen. Fortschritte Neurologie Psychiatrie 73(suppl 1):96–102CrossRef
Kapfhammer HP (2018) Acute and long-term mental and physical sequelae in the aftermath of traumatic exposure – some remarks on “the body keeps the score”. Psychiatr Danubina 30:254–272CrossRef
Karaiskos D, Tzavellas E, Ilias I et al (2013) Agomelatine and sertraline for the treatment of depression in type 2 diabetes mellitus. Int J Clin Pract 67:257–260CrossRef
Kasteleyn MJ, de Vries L, van Puffelen AL et al (2015) Diabetes-related distress over the course of illness: results from the diacourse study. Diabet Med 32:1617–1624CrossRef
Katon J, Mattocks K, Zephyrin L et al (2014) Gestational diabetes and hypertensive disorders of pregnancy among women veterans deployed in service of operations in Afghanistan and Iraq. J Womens Health (Larchmt) 23:792–800CrossRef
Katon W, Pedersen HS, Ribe AR et al (2015) Effect of depression and diabetes mellitus on the risk for dementia: a national population-based cohort study. JAMA Psychiat 72:612–619CrossRef
Katon W, Russo J, Lin EH et al (2009) Depression and diabetes: factors associated with major depression and five-year follow-up. Psychosomatics 50:570–579CrossRef
Katon WJ, Russo JE, Heckbert SR et al (2010) The relationship between changes in depression symptoms and changes in health risk behaviors in patients with diabetes. Int J Geriatr Psychiatry 25:466–475CrossRef
Katon WJ, Rutter C, Simon G et al (2005) The association of comorbid depression with mortality in patients with type 2 diabetes. Diabetes Care 28:2668–2672CrossRef
Katon WJ, von Korff M, Lin EHB et al (2004) The pathways study: a randomized trial of collaborative care in patients with diabetes and depression. Arch Gen Psychiatry 61:1042–1049CrossRef
Kautzky-Willer A, Harreiter J, Winhofer-Stöckl Y et al (2019) Gravidität bei vorbestehendem Diabetes (Update 2019). Wien Klin Wochenschr 131(Suppl 1):103–109CrossRef
Kemp CG, Johnson LCM, Sagar R et al (2022) Effect of a collaborative care model on anxiety symptoms among patients with depression and diabetes in India: the INDEPENDENT randomized clinical trial. Gen Hosp Psychiatry 74:39–45CrossRef
Khaledi M, Haghighatdoost F, Feizi A, Aminorroaya A (2019) The prevalence of comorbid depression in patients with type 2 diabetes: an updated systematic review and meta-analysis on huge number of observational studies. Acta Diabetol 56:631–650CrossRef
Khazaie H, Rahimi M, Tatari F, et al (2011) Treatment of depression in type 2 diabetes with Fluoxetine or Citalopram? Neurosciences (Riyadh) 16:42–45
Kivimäki M, Pentti J, Ferrie JE et al (2018) Work stress and risk of death in men and women with and without cardiometabolic disease: a multicohort study. Lancet Diabetes Endocrinol 6:705–713CrossRef
Knol MJ et al (2006) Depression as a risk factor for the onset of type 2 diabetes mellitus. A meta-analysis. Diabetologia 49:837–845CrossRef
Komorousova J, Beran J, Rusavy Z, Jankovec Z (2010) Glycemic control improvement through treatment of depression using antidepressant drugs in patients with diabetes mellitus type 1. Neuro Endocrinol Lett 31:801–806
Koob GF, Schulkin J (2019) Addiction and stress: an allostatic view. Neurosci Biobehav Rev 106:245–262CrossRef
Koob GF, Volkow ND (2016) Neurobiology of addiction: a neurocircuitry analysis. Lancet Psychiatry 3:760–773CrossRef
Koper JW, van Rossum EF, van den Akker EL (2014) Glucocorticoid receptor polymorphisms and haplotypes and their expression in in health and disease. Steroids 92:62–73CrossRef
Kovacs M, Obrosky DS, Goldston D, Drash A (1997) Major depressive disorder in youths with IDDM. A controlled prospective study of course and outcome. Diabetes Care 20:45–51CrossRef
Koves IH, Roth C (2018) Genetic and syndromic causes of obesity and its management. Indian J Pediatr 85:478–485CrossRef
Krischer JP, Liu X, Vehik K et al (2019) Predicting islet cell autoimmunity and type 1 diabetes: an 8-year TEDDY study progress report. Diabetes Care 42:1051–1060CrossRef
Kumar PR, Chatterjee A, Behera P, J, Patnaik S, (2019) Effect of sertraline as an add-on therapy in T2DM patients with comorbid depression: an open Label randomized controlled trial. Indian J Endocrinol Metab 23:357–362CrossRef
Kyrou I, Tsigos C (2009) Stress hormones: physiological stress and regulation of metabolism. Curr Opin Pharmacol 9:787–793CrossRef
Lambert EA, Straznicky NE, Dixon JB, Lambert GW (2015) Should the sympathetic nervous system be a target to improve cardiometabolic risk in obesity? Am J Physiol Heart Circ Physiol 309:H244-258CrossRef
Lambert GW, Schlaich MP, Eikelis N, Lambert EA (2019) Sympathetic activity in obesity: a brief review of methods and supportive data. Ann N Y Acad Sci 1454:56–67CrossRef
Lang UE, Walter M (2017) Depression in the context of medical disorders: new pharmacological pathways revisited. Neurosignals 25:54–73CrossRef
Laron Z (2009) Insulin and the brain. Arch Physiol Biochem 115:112–116
Laursen KR, Hulman A, Witte DR, Terkildsen Maindal H (2017) Social relations, depressive symptoms, and incident type 2 diabetes mellitus: the english longitudinal study of ageing. Diabetes Res Clin Pract 126:86–94CrossRef
Lavretsky H, Zheng L, Weiner MW et al (2008) The MRI brain correlates of depressed mood, anhedonia, apathy, and anergia in older adults with and without cognitive impairment or dementia. Int J Geriatr Psychiatry 23:1040–1050CrossRef
Leclercq S, Forsythe P, Bienenstock J (2016) Posttraumatic stress disorder: does the gut microbiome hold the key? Can J Psychiatry 61:204–213CrossRef
Lee PC, Dixon JB (2017) Food for thought: reward mechanisms and hedonic overeating in obesity. Curr Obes Rep 6:353–361CrossRef
Leigh SJ, Morris MJ (2018) The role of reward circuitry and food addiction in the obesity epidemic: an update. Biol Psychol 131:31–42CrossRef
Lennerz B, Lennerz JK (2018) Food addiction, high-glycemic-index carbohydrates, and obesity. Clin Chem 64:64–71CrossRef
Levenson JL, Myers AK (2019) Endocrine and metabolic disorders. In: Levenson JL (Hrsg) The American psychiatric association publishing textbook of psychosomatic medicine and consultation-liaison psychiatry, 3. Aufl. American Psychiatric Association Publishing, Washington, DC, S 593–623
Li C, Xu D, Hu M et al (2017) A systematic review and meta-analysis of randomized controlled trials of cognitive behavior therapy for patients with diabetes and depression. J Psychosom Res 95:44–54CrossRef
Li HQ, Chi S, Dong Q1 Yu JT (2019) Pharmacotherapeutic strategies for managing comorbid depression and diabetes. Expert Opin Pharmacother 20:1589–1599
Licht CMM, Vreeburg SA, van Reedt Dortland AKB et al (2010) Increased sympathetic and decreased parasympathetic activity rather than changes in hypothalamic-pituitary-adrenal axis activity is associated with metabolic abnormalities. J Clin Endocrinol Metab 95:2458–2466CrossRef
Lin EH, Rutter CM, Katon W et al (2010) Depression and advanced complications of diabetes: a prospective cohort study. Diabetes Care 33:264–269CrossRef
Lin EHB, Katon W, von Korff M et al (2004) Relationship of depression and diabetes self-care, medication adherence, and preventive care. Diabetes Care 27:2154–2160CrossRef
Lindgren E, Gray K, Miller G, et al (2018) Food addiction: a common neurobiological mechanism with drug abuse. Front Biosci (Landmark Ed) 23:811–836
Littorin B, Sundkvist G, Nyström L, et al, Diabetes Incidence Study in Sweden (DISS) (2001) Family characteristics and life events before the onset of autoimmune type 1 diabetes in young adults: a nationwide study. Diabetes Care 24:1033–1037
Lloyd CE, Nouwen A, Sartorius N et al (2018) Prevalence and correlates of depressive disorders in people with Type 2 diabetes: results from the International Prevalence and Treatment of Diabetes and Depression (INTERPRET-DD) study, a collaborative study carried out in 14 countries. Diabet Med 35:760–769CrossRef
Lohr JB, Palmer BW, Eidt CA et al (2015) Is post-traumatic stress disorder associated with premature senescence? A review of the literature. Am J Geriatr Psychiatry 23:709–725CrossRef
Lombardi A, Tsomos E, Hammerstad SS, Tomer Y (2018) Interferon alpha: the key trigger of type 1 diabetes. J Autoimmun 94:7–15CrossRef
Lotfy M, Adeghate J, Kalasz H, Singh J, Adeghate E (2017) Chronic complications of diabetes mellitus: a mini review. Curr Diabetes Rev 13:3–10CrossRef
Ludman E, KatonW RJ et al (2006) Panic episodes among patients with diabetes. Gen Hosp Psychiatry 28:475–481CrossRef
Lukaschek K, Baumert J, Kruse J et al (2013) Relationship between posttraumatic stress disorder and type 2 diabetes in a population-based cross-sectional study with 2970 participants. J Psychosom Res 74:340–345CrossRef
Lustman PJ, Anderson RJ, Freedland KE et al (2000a) Depression and poor glycemic control: a meta-analytic review of the literature. Diabetes Care 23:934–942CrossRef
Lustman PJ, Freedland KE, Griffith LS et al (2000b) Fluoxetine for depression in diabetes: a randomized double-blind placebo-controlled trial. Diabetes Care 23:618–623CrossRef
Lustman PJ, Griffith LS, Clouse RE (1988) Depression in adults with diabetes: results of a 5-year follow-up study. Diabetes Care 11:605–612CrossRef
Lustman PJ, Griffith LS, Clouse RE et al (1986) Psychiatric illness in diabetes mellitus: relationship to symptoms and glucose control. J Nerv Ment Dis 174:736–742CrossRef
Lustman PJ, Griffith LS, Clouse RE et al (1997) Effects of nortriptyline on depression and glycemic control in diabetes: results of a double-blind, placebo-controlled trial. Psychosom Med 59:241–250CrossRef
Lustman PJ, Griffith LS, Freedland KE, Kissel SS, Clouse RE (1998) Cognitive behavior therapy for depression in type 2 diabetes mellitus. A randomized, controlled trial. Ann Intern Med 129:613–621CrossRef
Lustman PJ, Williams MM, Sayuk GS et al (2007) Factors influencing glycemic control in type 2 diabetes during acute- and maintenance phase treatment of major depressive disorder with bupropion. Diabetes Care 30:459–466CrossRef
Mack LR, Tomich PG (2017) Gestational diabetes: diagnosis, classification, and clinical care. Obstet Gynecol Clin North Am 44:207–217CrossRef
Mak JKL, Lee AH, Pham NM et al (2019) Gestational diabetes and postnatal depressive symptoms: a prospective cohort study in Western China. Women Birth 32:e427–e431CrossRef
Mansur RB, Brietzke E, McIntyre RS (2015) Is there a „metabolic-mood syndrome“? A review of the relationship between obesity and mood disorders. Neurosci Biobehav Rev 52:89–104CrossRef
Marijnissen RM, Vogelzangs N, Mulder ME et al (2017) Metabolic dysregulation and late-life depression: a prospective study. Psychol Med 47:1041–1052CrossRef
Markowitz SM, Gonzalez JS, Wilkinson JL, Safren SA (2011) A review of treating depression in diabetes: emerging findings. Psychosomatics 52:1–18CrossRef
Martins LB, Monteze NM, Calarge C et al (2019) Pathways linking obesity to neuropsychiatric disorders. Nutrition 66:16–21CrossRef
Martyn-Nemeth P, Duffecy J2, Quinn L, et al. (2019) A cognitive behavioral therapy intervention to reduce fear of hypoglycemia in young adults with type 1 diabetes (FREE): study protocol for a randomized controlled trial.Trials 20:796. https://​doi.​org/​10.​1186/​s13063-019-3876-4
Martyn-Nemeth P, Quinn L, Penckofer S et al (2017) Fear of hypoglycemia: influence on glycemic variability and self-management behavior in young adults with type 1 diabetes. J Diabetes Complications 31:735–741CrossRef
Mathiesen AS, Egerod I, Jensen T et al (2018) Psychosocial interventions for reducing diabetes distress in vulnerable people with type 2 diabetes mellitus: a systematic review and meta-analysis. Diabetes Metab Syndr Obes 12:19–33CrossRef
McCoy MA, Theeke LA (2019) A systematic review of the relationships among psychosocial factors and coping in adults with type 2 diabetes mellitus. Int J Nurs Sci 6:468–477
McIntyre RE, Kenna HA, Nguyen HT et al (2010) Brain volume abnormalities and neurocognitive deficits in diabetes mellitus: points of pathophysiological commonality with mood disorders? Adv Ther 27:63–80CrossRef
McIntyre RS, Soczynska JK, Konarski JZ, Kennedy SH (2006) The effect of antidepressants on glucose homeostasis and insulin sensitivity: synthesis and mechanisms. Exp Opin Drug Saf 5:157–168CrossRef
Mellon SH, Gautam A, Hammamieh R et al (2018) Metabolism, metabolomics, and inflammation in posttraumatic stress disorder. Biol Psychiatry 83:866–875CrossRef
Mendenhall E, Kohrt BA, Norris SA, Ndetei D, Prabhakaran D (2017) Non-communicable disease syndemics: poverty, depression, and diabetes among low-income populations. Lancet 389(10072):951–963CrossRef
Meng R, Liu N, Yu C, et al.; China Kadoorie Biobank collaborative group (2018) Association between major depressive episode and risk of type 2 diabetes: a large prospective cohort study in Chinese adults.. J Affect Disord 234:59–66
Meule A (2019) A critical examination of the practical implications derived from the food addiction concept. Curr Obes Rep 8:11–17CrossRef
Meurs M, Roest AM, Wolffenbuttel BH et al (2016) Association of depressive and anxiety disorders with diagnosed versus undiagnosed diabetes: an epidemiological study of 90,686 participants. Psychosom Med 78:233–241CrossRef
Mezuk B, Eaton WW, Albrecht S, Golden SH (2008) Depression and type 2 diabetes over the lifespan: a meta-analysis. Diabetes Care 31:2383–2390CrossRef
Milaneschi Y, Simmons WK, van Rossum EFC, Penninx BW (2019) Depression and obesity: evidence of shared biological mechanisms. Mol Psychiatry 24:18–33CrossRef
Miller-Archie SA, Jordan HT, Ruff RR et al (2014) Posttraumatic stress disorder and new-onset diabetes among adult survivors of the world trade center disaster. Prev Med 66:34–38CrossRef
Moise N, Wainberg M, Shah RN (2021) Primary care and mental health: where do we go from here? World J Psychiatry 11:271–276CrossRef
Mommersteeg PM, Herr R, Zijlstra WP, Schneider S, Pouwer F (2012) Higher levels of psychological distress are associated with a higher risk of incident diabetes during 18-year follow-up: results from the British household panel survey. BMC Public Health 12:1109. https://​doi.​org/​10.​1186/​1471-2458-12-1109CrossRef
Monaghan M, Clary L, Stern A et al (2015) Protective factors in young children with type 1 diabetes. J Pediatr Psychol 40:878–887CrossRef
Moraitis AG, Block T, Nguyen D, Belanoff JK (2017)The role of glucocorticoid receptors in metabolic syndrome and psychiatric illness. J Steroid Biochem Mol Biol 165:114–120
Moreira H, Canavarro MC (2016) Parental attachment insecurity and parenting stress: the mediating role of parents’ perceived impact of children’s diabetes on the family. Fam Syst Health 34:240–249CrossRef
Moulton CD, Pickup JC, Ismail K (2015) The link between depression and diabetes: the search for shared mechanisms. Lancet Diabetes Endocrinol 3:461–471CrossRef
Müller-Wieland D, Renz-Polster H, Frerks HJ (2018) Stoffwechsel. In: Braun J, Müller-Wieland D, Renz-Polster H, Krautzig S (2018) Basislehrbuch Innere Medizin. 6. Aufl. Elsevier, Urban & Fischer, München, 733–772
Musselman DL, Betan E, Larsen H, Philips LS (2003) The relationship of depression to diabetes – type 1 and type 2. Epidemiology, biology, and treatment. Biol Psychiatry 54:317–329CrossRef
Musselman DL, Bowling A, Gilles N et al (2006) The interrelationship of depression and diabetes. In: Steptoe A (Hrsg) Depression and physical illness. Cambridge University Press, Cambridge, S 165–194CrossRef
Mustonen N, Siljander H, Peet A et al (2017) Early childhood infections precede development of beta-cell autoimmunity and type 1 diabetes in children with HLA-conferred disease risk. Pediatr Diabetes 19:293–299CrossRef
Naicker K, Johnson JA, Skogen JC et al (2017) Type 2 diabetes and comorbid symptoms of depression and anxiety: longitudinal associations with mortality risk. Diabetes Care 40:352–358CrossRef
Naskar S, Victor R, Nath K (2017) Depression in diabetes mellitus-a comprehensive systematic review of literature from an Indian perspective. Asian J Psychiatr 27:85–100CrossRef
Nefs G, Hendrieckx C, Reddy P et al (2019) Comorbid elevated symptoms of anxiety and depression in adults with type 1 or type 2 diabetes: results from the international diabetes MILES study. J Diabetes Complications 33:523–529CrossRef
Nicolaides NC, Kyratzi E, Lamprokostopoulo A et al (2015) Stress, the stress system and the role of glucocorticoids. NeuroImmunoModulation 22:6–19CrossRef
Nieman LK (2015) Cushing´s syndrome: update in signs, symptoms and biochemical screening. Eur J Endocrinol 173:M33-38CrossRef
Nieuwesteeg AM, Hartman EE, Aanstoot HJ et al (2016) The relationship between parenting stress and parent-child interaction with health outcomes in the youngest patients with type 1 diabetes (0–7 years). Eur J Pediatr 175:329–338CrossRef
Niles AN, O’Donovan A (2019) Comparing anxiety and depression to obesity and smoking as predictors of major medical illnesses and somatic symptoms. Health Psychol 38:172–181CrossRef
Nip ASY, Reboussin BA, Dabelea D et al (2019) Disordered eating behaviors in youth and young adults with type 1 or type 2 diabetes receiving insulin therapy: the SEARCH for diabetes in youth study. Diabetes Care 42:859–866CrossRef
Nouwen A, Adriaanse MC, van Dam K et al (2019) Longitudinal associations between depression and diabetes complications: a systematic review and meta-analysis. Diabet Med 36:1562–1572CrossRef
Nouwen A, Nefs G, Caramlau I, et al., European Depression in Diabetes Research Consortium (2011) Prevalence of depression in individuals with impaired glucose metabolism or undiagnosed diabetes: a systematic review and meta-analysis of the European Depression in Diabetes (EDID) Research Consortium. Diabetes Care 34:752–762
Nouwen A, Winkley K, Twisk J, et al., European Depression in Diabetes (EDID) Research Consortium (2010) Type 2 diabetes mellitus as a risk factor for the onset of depression: a systematic review and meta-analysis. Diabetologia 53:2480–2486
Nusslock R, Miller GE (2016) Early-life adversity and physical and emotional health across the lifespan: a neuro-immune network hypothesis. Biol Psychiatry 80:23–32CrossRef
Nyberg ST, Fransson EI, Heikkilä K et al (2014) Job strain as a risk factor for type 2 diabetes: a pooled analysis of 124,808 men and women. Diabetes Care 37:2268–2275CrossRef
Nygren M, Carstensen J, Koch F, Ludvigsson J, Frostell A (2015) Experience of a serious life event increases the risk for childhood type 1 diabetes: the ABIS population-based prospective cohort study. Diabetologia 58:1188–1197CrossRef
Oram RA, Redondo MJ (2019) New insights on the genetics of type 1 diabetes. Curr Opin Endocrinol Diabetes Obes 26:181–187CrossRef
Osadchiy V, Mayer EA, Bhatt R et al (2019) History of early life adversity is associated with increased food addiction and sex-specific alterations in reward network connectivity in obesity. Obes Sci Pract 5:416–436CrossRef
Pan A, Keum N, Okereke OI et al (2012) Bidirectional association between depression and metabolic syndrome: a systematic review and meta-analysis of epidemiological studies. Diabetes Care 35:1171–1180CrossRef
Park M, Katon WJ, Wolf FM (2013) Depression and risk of mortality in individuals with diabetes: a meta-analysis and systematic review. Gen Hosp Psychiatry 35:217–225CrossRef
Patel SS, Mehta V, Changotra H, Udayabanu M4 (2016) Depression mediates impaired glucose tolerance and cognitive dysfunction: a neuromodulatory role of rosiglitazone. Horm Behav 78:200–210
Penckofer SM, Ferrans C, Mumby P et al (2012) A psychoeducational intervention (SWEEP) for depressed women with diabetes. Ann Behav Med 44:192–206CrossRef
Peng TY, Ehrlich SF, Crites Y et al (2017) Trends and racial and ethnic disparities in the prevalence of pregestational type 1 and type 2 diabetes in Northern California: 1996–2014. Am J Obstet Gynecol 216:177.e1-177.e8CrossRef
Penninx BWJH (2017) Depression and cardiovascular disease: epidemiological evidence on their linking mechanisms. Neurosci Biobheav Rev 74:277–286CrossRef
Penninx BWJH, Lange SMM (2018) Metabolic syndrome in psychiatric patients: overview, mechanisms, and implications. Dialogues Clin Neurosci 20:63–73CrossRef
Perrin N, Bodicoat DH, Davies MJ et al (2019) Effectiveness of psychoeducational interventions for the treatment of diabetes-specific emotional distress and glycaemic control in people with type 2 diabetes: a systematic review and meta-analysis. Prim Care Diabetes 13:556–567CrossRef
Perrin NE, Davies MJ, Robertson N et al (2017) The prevalence of diabetes-specific emotional distress in people with Type 2 diabetes: a systematic review and meta-analysis. Diabet Med 34:1508–1520CrossRef
Peterson CM, Fischer S2, Young-Hyman D (2015) Topical review: a comprehensive risk model for disordered eating in youth with type 1 diabetes. J Pediatr Psychol 40:385–390
Peterson CM, Young-Hyman D, Fischer S et al (2018) Examination of psychosocial and physiological risk for bulimic symptoms in youth with type 1 diabetes transitioning to an insulin pump: a pilot study. J Pediatr Psychol 43:83–93CrossRef
Petrak F, Hardt J, Wittchen HU et al (2003) Prevalence of psychiatric disorders in an onset cohort of adults with type 1 diabetes. Diabetes Metab Res Rev 19:216–222CrossRef
Petrak F, Herpertz S, Albus C et al (2015a) Cognitive behavioral therapy versus sertraline in patients with depression and poorly controlled diabetes: the Diabetes and Depression (DAD) study: a randomized controlled multicenter trial. Diabetes Care 38:767–775CrossRef
Petrak F, Baumeister H, Skinner TC et al (2015b) Depression and diabetes: treatment and health-care delivery. Lancet Diabetes Endocrinol 3:472–485CrossRef
Petrak F, Röhrig B, Ismail K (2018) Depression and diabetes. Endotext – comprehensive free online endocrinology book, www.​endotext.​org. Zugegriffen: 14. Jan. 2018
Picozzi A, DeLuca F (2019) Depression and glycemic control in adolescent diabetics: evaluating possible association between depression and hemoglobin A1c. Public Health 170:32–37CrossRef
Pierce JS, Kozikowski C, Lee JM, Wysocki T (2017) Type 1 diabetes in very young children: a model of parent and child influences on management and outcomes. Pediatr Diabetes 18:17–25CrossRef
Piette JD, Richardson C, Himle J et al (2011) A randomized trial of telephonic counseling plus walking for depressed diabetes patients. Med Care 49:641–648CrossRef
Pinhas-Hamiel O, Hamiel U, Levy-Shraga Y (2015) Eating disorders in adolescents with type 1 diabetes: challenges in diagnosis and treatment. World J Diabetes 6:517–526CrossRef
Pompili M, Forte A, Lester D et al (2014) Suicide risk in type 1 diabetes mellitus: a systematic review. J Psychosom Res 76:352–360CrossRef
Power F, Mezuk B, Tabák AG (2018) Diabetes mellitus. In: Kivimäki M, Batty GD, Steptoe A, Kawachi I (Hrsg) The routledge international handbook of psychosocial epidemiology. Routledge, New York, S 215–246
Proudfoot J, Clarke J, Gunn J et al (2017) A web-based public health intervention to reduce functional impairment and depressive symptoms in adults with type 2 diabetes (The SpringboarD Trial): randomized controlled trial protocol. JMIR Res Protoc 6:e145. https://​doi.​org/​10.​2196/​resprot.​7348CrossRef
Qu W, Meng P (2005) Relationship between blood glucose levels in patients with type 2 diabetes mellitus, depression and anxiety and the anti-depression/anxiety intervention. Chin J Clin Rehabil 9:213–215
Ramos-Rodríguez M, Raurell-Vila H, Colli ML et al (2019) The impact of proinflammatory cytokines on the β-cell regulatory landscape provides insights into the genetics of type 1 diabetes. Nat Genet 51:1588–1595CrossRef
Rasgon NL, McEwen BS (2016) Insulin resistance – a missing link no more. Mol Psychiatry 21:1648–1652CrossRef
Raymaekers K, Prikken S, Vanhalst J et al (2020) The social context and illness identity in youth with type 1 diabetes: a three-wave longitudinal study. J Youth Adolesc 49:449–466CrossRef
Rechenberg K, Grey M, Sadler L (2017) Stress and posttraumatic stress in mothers of children with type 1 diabetes. J Fam Nurs 23:201–225CrossRef
Rewers M, Ludvigsson J (2016) Environmental risk factors for type 1 diabetes. Lancet 387(10035):2340–2348CrossRef
Richardson LK, Egede LE, Mueller M, Echols CL, Gebregziabher M (2008) Longitudinal effects of depression on glycemic control in veterans with type 2 diabetes. Gen Hosp Psychiatry 30:509–514CrossRef
Rieder R, Wisniewski PJ, Alderman BL, Campbell SC (2017) Microbes and mental health: a review. Brain Behav Immun 66:9–17CrossRef
Roberts AL, Agnew-Blais JC, Spiegelman D et al (2015) Posttraumatic stress disorder and incidence of type 2 diabetes mellitus in a sample of women: a 22-year longitudinal study. JAMA Psychiat 72:203–210CrossRef
Roopan S, Larsen ER (2017) Use of antidepressants in patients with depression and comorbid diabetes mellitus: a systematic review. Acta Neuropsychiatr 29:127–139CrossRef
Rosenbaum S, Stubbs B, Ward PB et al (2015) The prevalence and risk of metabolic syndrome and its components among people with posttraumatic stress disorder: a systematic review and meta-analysis. Metabolism 64:926–933CrossRef
Ross GP, Falhammar H, Chen R et al (2016) Relationship between depression and diabetes in pregnancy: a systematic review. World J Diabetes 7:554–571CrossRef
Rotella F, Mannucci E (2013) Depression as a risk factor for diabetes: a meta-analysis of longitudinal studies. J Clin Psychiatry 74:31–37CrossRef
Roth R, Lynch K, Hyöty H et al (2019) The association between stressful life events and respiratory infections during the first 4 years of life: the environmental determinants of diabetes in the young study. Stress Health 35:289–303CrossRef
Ruohomäki A, Toffol E, Upadhyaya S et al (2018) The association between gestational diabetes mellitus and postpartum depressive symptomatology: a prospective cohort study. J Affect Disord 241:263–268CrossRef
Rustad JK, Musselman DL, Nemeroff CB (2011) The relationsip of depression and diabetes: pathophysiological and treatment implications. Psychoneuroendocrinol 36:1276–1286CrossRef
Safren SA, Gonzalez JS, Wexler DJ et al (2014) A randomized controlled trial of cognitive behavioral therapy for adherence and depression (CBT-AD) in patients with uncontrolled type 2 diabetes. Diabetes Care 37:625–633CrossRef
Sapolsky RM (2000) Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders. Arch Gen Psychiatry 57:925–935CrossRef
Sarkar S, Balhara YP (2014) Diabetes mellitus and suicide. Indian J Endocrinol Metab 18:468–474CrossRef
Sartorius N (2018) Depression and diabetes. Dialogues Clin Neurosci 20:47–52
Sayuk GS, Gott BM, Nix BD, Lustman PJ (2011) Improvement in sexual functioning in patients with type 2 diabetes and depression treated with bupropion. Diabetes Care 34:332–334CrossRef
Scherrer JF, Salas J, Lustman PJ et al (2018) The role of obesity in the association between posttraumatic stress disorder and incident diabetes. JAMA Psychiat 75:1189–1198CrossRef
Scherrer JF, Salas J, Norman SB et al (2019) Association between clinically meaningful posttraumatic stress disorder improvement and risk of type 2 diabetes. JAMA Psychiat 76:1159–1166CrossRef
von Schnurbein J, Wabitsch M (2017) Monogene Adipositas. Pathophysiologie – Diagnostik – Therapieoptionen. Med Gen 4:348–359
Seligowski AV, Pless Kaiser AP et al (2013) Sleep quality as a potential mediator between psychological distress and diabetes quality of life in veterans with type 2 diabetes. J Clin Psychol 69:1121–1131CrossRef
Semenkovich K, Brown ME, Svrakic DM, Lustman PJ (2015) Depression in type 2 diabetes mellitus: prevalence, impact, and treatment. Drugs 75:577–587CrossRef
Sepa A, Frodi A, Ludvigsson J (2005) Mothers’ experiences of serious life events increase the risk of diabetes-related autoimmunity in their children. Diabetes Care 28:2394–2399CrossRef
Serretti A, Mandelli L (2010) Antidepressants and body weight. J Clin Psychiatry 71:1259–1272CrossRef
Shaban C (2013) Diabulimia: mental health condition or media hyperbole? Pract Diabetes 30:104–105CrossRef
Shang X, Peng W, Hill E et al (2019) Incidence of medication-treated depression and anxiety associated with long-term cancer, cardiovascular disease, diabetes and osteoarthritis in community-dwelling women and men. EClinicalMedicine 15:23–32CrossRef
Sharif F, Masoudi M, Ghanizadeh A et al (2014) The effect of cognitive-behavioral group therapy on depressive symptoms in people with type 2 diabetes: a randomized controlled clinical trial. Iran J Nurs Midwifery Res 19:529–536
Sharif K, Watad A, Coplan L et al (2018) Psychological stress and type 1 diabetes mellitus: what is the link? Expert Rev Clin Immunol 14:1081–1088CrossRef
Shaw JG, Asch SM, Katon JG et al (2017) Post-traumatic stress disorder and antepartum complications: a novel risk factor for gestational diabetes and preeclampsia. Paediatr Perinat Epidemiol 31:185–194CrossRef
Simon GE, Von Korff M, Saunders K et al (2006) Association between obesity and psychiatric disorders in the US adult population. Arch Gen Psychiatry 63:824–830CrossRef
Singer M, Bulled N, Ostrach B, Mendenhall E (2017) Syndemics and the biosocial conception of health. Lancet 389(10072):941–950CrossRef
Singhal A, Ross J, Seminog O et al (2014) Risk of self-harm and suicide in people with specific psychiatric and physical disorders: comparisons between disorders using English national record linkage. J R Soc Med 107:194–204CrossRef
Smith KJ, Béland M, Clyde M et al (2013) Association of diabetes with anxiety: a systematic review and meta-analysis. J Psychosom Res 74:89–99CrossRef
Smith KJ, Deschênes SS, Schmitz N (2018) Investigating the longitudinal association between diabetes and anxiety: a systematic review and meta-analysis. Diabet Med 35:677–693CrossRef
Snoek FJ, Bremmer MA, Hermanns N (2015) Constructs of depression and distress in diabetes: time for an appraisal. Lancet Diabetes Endocrinol 3:450–460CrossRef
Soltész G, Jeges S, Dahlquist G (1994) Non-genetic risk determinants for type 1 (insulin dependent) diabetes mellitus in childhood. Acta Paediatr 83:730–735CrossRef
Sommese L, Zullo A, Mancini FP et al (2017) Clinical relevance of epigenetics in the onset and management of type 2 diabetes mellitus. Epigenetics 12:401–415CrossRef
Song QQ, Xie WY, Tang YJ, Zhang J, Liu J (2017) Genetic variation in the glucocorticoid pathway involved in interindividual differences in the glucocorticoid treatment. Pharmacogenomics 18:293–316CrossRef
Sonnino N, Fava GA (2001) Psychiatric disorders associated with cushing´s syndrome. CNS Drugs 15:361–373CrossRef
Sotelo JL, Nemeroff CB (2017) Depression as a systemic disease. Pers Med Psychiatry 1:11–25
Sridhar GR (2022) Can the management of depression in type 2 diabetes be democratized? World J Diabetes 13:203–212CrossRef
Stalder T, Steudte-Schmiedgen S, Alexander N et al (2017) Stress-related and basic determinants of hair cortisol in humans: a meta-analysis. Psychoneuroendocrinology 77:261–274CrossRef
Stefanovics EA, Potenza MN, Pietrzak RH (2018) The physical and mental health burden of obesity in U.S. veterans: results from the national health and resilience in veterans study. J Psychiatr Res 103:112–119CrossRef
Steptoe A (2006) Depression and physical activity. In: Steptoe A (Hrsg) Depression and physical illness. Cambridge University Press, Cambridge, S 348–368CrossRef
Stiefel F, Zdrojewski C, Bel Hadj F et al (2008) Effects of a multifaceted psychiatric intervention targeted for the complex medically ill: a randomized controlled trial. Psychother Psychosom 77:247–256CrossRef
Subba R, Sandhir R, Singh SP et al (2021) Pathophysiology linking depression and type 2 diabetes: Psychotherapy, physical exercise, and fecal microbiome transplantation as damage control. Eur J Neurosci 53:2870–2900CrossRef
Sudhir PM (2017) Advances in psychological interventions for lifestyle disorders: overview of interventions in cardiovascular disorder and type 2 diabetes mellitus. Curr Opin Psychiatry 30:346–351CrossRef
Sullivan MD, O’Connor P, Feeney P et al (2012) Depression predicts all-cause mortality: epidemiological evaluation from the ACCORD HRQL substudy. Diabetes Care 35:1708–1715CrossRef
Tabák AG, Akbaraly TN, Batty GD, Kivimäki M (2014) Depression and type 2 diabetes: a causal association? Lancet Diabetes Endocrinol 2:236–245CrossRef
Tang F, Wang G, Lian Y (2017) Association between anxiety and metabolic syndrome: a systematic review and meta-analysis of epidemiological studies. Psychoneuroendocrinology 77:112–121CrossRef
Tovote KA, Fleer J, Snippe E et al (2014) Individual mindfulness-based cognitive therapy and cognitive behavior therapy for treating depressive symptoms in patients with diabetes: results of a randomized controlled trial. Diabetes Care 37:2427–2434CrossRef
Tracy EL, Berg CA, Baker AC et al (2019) Health-risk behaviors and type 1 diabetes outcomes in the transition from late adolescence to early emerging adulthood. Child Health Care 48:285–300CrossRef
Trento M, Charrier L, Salassa M et al (2015) Depression, anxiety and cognitive function in patients with type 2 diabetes: an 8-year prospective observational study. Acta Diabetol 52:1157–1166CrossRef
Trief PM, Ouimette P, Wade M, Shanahan P, Weinstock RS (2006) Post-traumatic stress disorder and diabetes: co-morbidity and outcomes in a male veterans sample. J Behav Med 29:411–418CrossRef
Tu HP, Lin CH, Hsieh HM et al (2017) Prevalence of anxiety disorder in patients with type 2 diabetes: a nationwide population-based study in Taiwan 2000–2010. Psychiatr Q 88:75–91CrossRef
Turin A, Radobuljac MD (2021) Psychosocial factors affecting the etiology and management of type 1 diabetes mellitus: a narrative review. World J Diabetes 12:1518–1529CrossRef
Uchendu C, Blake H (2017) Effectiveness of cognitive-behavioural therapy on glycaemic control and psychological outcomes in adults with diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials. Diabet Med 34:328–339CrossRef
Vaccarino V, Goldberg J, Magruder KM, et al. (2014) Posttraumatic stress disorder and incidence of type-2 diabetes: a prospective twin study. .J Psychiatr Res 56:158–164
van Bastelaar KM, Pouwer F, Cuijpers P et al (2011) Web-based depression treatment for type 1 and type 2 diabetic patients: a randomized, controlled trial. Diabetes Care 34:320–325CrossRef
van den Berk-Clark C, Secrest S, Walls J et al (2018) Association between posttraumatic stress disorder and lack of exercise, poor diet, obesity, and co-occuring smoking: a systematic review and meta-analysis. Health Psychol 37:407–416CrossRef
van der Feltz-Cornelis CM, Nuyen J, Stoop C et al (2010) Effect of interventions for major depressive disorder and significant depressive symptoms in patients with diabetes mellitus: a systematic review and meta-analysis. Gen Hosp Psychiatry 32:380–395CrossRef
van der Valk ES, Savas M, van Rossum EFC (2018) Stress and obesity. Are there more susceptible individuals? Curr Obes Rep 7:193–203CrossRef
van der Valk ES, van den Akker ELT, Savas M et al (2019) A comprehensive diagnostic approach to detect underlying causes of obesity in adults. Obes Rev 20:795–804CrossRef
van Dooren FE1, Denollet J, Verhey FR, et al. (2016) Psychological and personality factors in type 2 diabetes mellitus, presenting the rationale and exploratory results from The Maastricht Study, a population-based cohort study. BMC Psychiatry 16:17. https://​doi.​org/​10.​1186/​s12888-016-0722-z
van Duinkerken E, Snoek FJ, de Wit M (2020) The cognitive and psychological effects of living with type 1 diabetes: a narrative review. Diabet Med 37:555–563CrossRef
van Leijden MJ, Penninx BWJH, Agyemang C et al (2018) The association of depression and posttraumatic stress disorder with the metabolic syndrome in a multi-ethnic cohort: the HELIUS study. Soc Psychiatry Psychiatr Epidemiol 53:921–930CrossRef
van Reedt Dortland AK, Giltay EJ, van Veen T, Zitman FG, Penninx BW (2010) Metabolic syndrome abnormalities are associated with severity of anxiety and depression and with tricyclic antidepressant use. Acta Psychiatr Scand 122:30–39CrossRef
van Sloten TT, Sedaghat S, Carnethon MR et al (2020) Cerebral microvascular complications of type 2 diabetes: stroke, cognitive dysfunction, and depression. Lancet Diabetes Endocrinol 8:325–336CrossRef
van Son J, Nyklíček I, Pop VJ et al (2014) Mindfulness-based cognitive therapy for people with diabetes and emotional problems: long-term follow-up findings from the DiaMind randomized controlled trial. J Psychosom Res 77:81–84CrossRef
Vancampfort D, Mitchell AJ, De Hert M et al (2015) Type 2 diabetes in patients with major depressive disorder: a meta-analysis of prevalence estimates and predictors. Depress Anxiety 32:763–773CrossRef
Vancampfort D, Rosenbaum S, Ward PB et al (2016) Type 2 diabetes among people with posttraumatic stress disorder: systematic review and meta-analysis. Psychosom Med 78:465–473CrossRef
Vaseghi H, Jadali Z (2016) Th1/Th2 cytokines in type 1 diabetes: relation to duration of disease and gender. Indian J Endocrinol Metab 20:312–316CrossRef
Vilar S, Castillo JM, Munuera Martínez PV et al (2018) Therapeutic alternatives in painful diabetic neuropathy: a meta-analysis of randomized controlled trials. Korean J Pain 31:253–260CrossRef
Virtanen M, Ferrie JE, Akbaraly T et al (2017) Metabolic syndrome and symptom resolution in depression: a 5-year follow-up of older adults. J Clin Psychiatry 78:e1–e7CrossRef
Virtanen M, Ferrie JE, Tabak AG et al (2014) Psychological distress and incidence of type 2 diabetes in high-risk and low-risk populations: the Whitehall II Cohort Study. Diabetes Care 37:2091–2097CrossRef
Vogelzangs N, Beekman AT, van Reedt Dortland AK et al (2014) Inflammatory and metabolic dysregulation and the 2-year course of depressive disorders in antidepressant users. Neuropsychopharmacology 39:1624–1634CrossRef
Vogelzangs N, Kritchevsky SB, Beekman AT et al (2008) Depressive symptoms and change in abdominal obesity in older persons. Arch Gen Psychiatry 65:1386–1393CrossRef
Volkow ND, Wise RA, Baler R (2017) The dopamine motive system: implications for drug and food addiction. Nat Rev Neurosci 18:741–752CrossRef
Wang F, Wang S, Zong QQ et al (2019) Prevalence of comorbid major depressive disorder in Type 2 diabetes: a meta-analysis of comparative and epidemiological studies. Diabet Med 36:961–969CrossRef
Wang MY, Tsai PS, Chou KR et al (2008) A systematic review of the efficacy of non-pharmacological treatments for depression on glycaemic control in type 2 diabetics. J Clin Nurs 17:2524–2530CrossRef
Wang TY, Wei HT, Liou YJ et al (2016) Risk for developing dementia among patients with posttraumatic stress disorder: a nationwide longitudinal study. J Affect Disord 205:306–310CrossRef
Wen FK, Crosby K, Miller BH et al (2020) Association of first-line antidepressants and incident adverse metabolic effects. Can Fam Physician 66:898–900CrossRef
Wester VL, Staufenbiel SM, Veldhorst MAB et al (2014) Long-term cortisol levels measured in scalp hair in obese patients. Obesity 22:1956–1958 CrossRef
Whitmer RA, Karter AJ, Yaffe K, Quesenberry CP Jr, Selby JV (2009) Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus. JAMA 301:1565–1572CrossRef
Whittemore R, Jaser S, Chao A, Jang M, Grey M (2012) Psychological experience of parents of children with type 1 diabetes: a systematic mixed-studies review. Diabetes Educ 38:562–579
Whitworth SR, Bruce DG, Starkstein SE et al (2017) Depression symptoms are persistent in Type 2 diabetes: risk factors and outcomes of 5-year depression trajectories using latent class growth analysis. Diabet Med 34:1108–1115CrossRef
Williams JW Jr, Katon W, Lin EHB et al (2004) The effectiveness of depression care management on diabetes-related outcomes in older patients. Ann Intern Med 140:1015–1024CrossRef
Williams MM, Clouse RE, Nix BD et al (2007) Efficacy of sertraline in prevention of depression recurrence in older versus younger adults with diabetes. Diabetes Care 30:801–806CrossRef
Willmann C, Eckstein S, Heni M (2018) Gehirn und Stoffwechsel. Diabetologe 14:509–518
Wilson CA, Newham J, Rankin J et al (2022) Systematic review and meta-analysis of risk of gestational diabetes in women with preconception mental disorders. J Psychiatr Res 149:293–306CrossRef
Winkley K, Upsher R, Stahl D et al (2020) Psychological interventions to improve self-management of type 1 and type 2 diabetes: a systematic review. Health Technol Assess 24:1–232CrossRef
Wisting L, Reas DL, Bang L et al (2017) Eating patterns in adolescents with type 1 diabetes: associations with metabolic control, insulin omission, and eating disorder pathology. Appetite 114:226–231CrossRef
Wolf EJ, Bovin MJ, Green JD et al (2016) Longitudinal associations between post-traumatic stress disorder and metabolic syndrome severity. Psychol Med 46:2215–2226CrossRef
Wong JJ, Addala A, Abujaradeh H et al (2020) Depression in context: important considerations for youth with type 1 vs type 2 diabetes. Pediatr Diabetes 21:135–142CrossRef
Woolf C, Muscara F, Anderson VA, McCarthy MC (2016) Early traumatic stress responses in parents following a serious illness in their child: a systematic review. J Clin Psychol Med Settings 23:53–66CrossRef
Worrall-Davies A, Owens D, Holland P, Haigh D (2002) The effect of parental expressed emotion on glycaemic control in children with type 1 diabetes. Parental expressed emotion and glycaemic control in children. J Psychosom Res 52:107–113CrossRef
Wou C, Unwin N, Huang Y, Roglic G (2019) Implications of the growing burden of diabetes for premature cardiovascular disease mortality and the attainment of the Sustainable Development Goal target 3.4. Cardiovasc Diagn Ther 9:140–149CrossRef
Wu LT, Ghitza UE, Zhu H et al (2018) Substance use disorders and medical comorbidities among high-need, high-risk patients with diabetes. Drug Alcohol Depend 186:86–93CrossRef
Xie J, Deng W (2017) Psychosocial intervention for patients with type 2 diabetes mellitus and comorbid depression: a meta-analysis of randomized controlled trials. Neuropsychiatr Dis Treat 13:2681–2690CrossRef
Xu Q, Anderson D, Lurie-Beck J (2011) The relationship between abdominal obesity and depression in the general population: a systematic review and meta-analysis. Obes Res Clin Pract 5:e267-360CrossRef
Xue H (2004) Paroxetine for depression in diabetes: a randomized controlled trial. Chin Mental Health J 18:735–737
Young-Hyman DL, Peterson CM, Fischer S et al (2016) Depressive symptoms, emotion dysregulation, and bulimic symptoms in youth with type 1 diabetes: varying interactions at diagnosis and during transition to insulin pump therapy. J Diabetes Sci Technol 10:845–851CrossRef
Yu M, Zhang X, Lu F, Fang L (2015) Depression and risk for diabetes: a meta-analysis. Can J Diabetes 39:266–272CrossRef
Zannas AS, Chrousos GP (2017) Epigenetic programming by stress and glucocorticoids along the human lifespan. Mol Psychiatry 22:640–646CrossRef
Zhang X, Norris SL, Gregg EW et al (2005) Depressive symptoms and mortality among persons with and without diabetes. Am J Epidemiol 161:652–660CrossRef
Zhuang QS, Shen L, Ji HF (2017) Quantitative assessment of the bidirectional relationships between diabetes and depression. Oncotarget 8:23389–23400CrossRef
Zullo A, Sommese L, Nicoletti G et al (2017) Epigenetics and type 1 diabetes: mechanisms and translational applications. Transl Res 185:85–93CrossRef
Metadaten
Titel
Diabetes mellitus
verfasst von
Hans-Peter Kapfhammer
Copyright-Jahr
2022
Verlag
Springer Berlin Heidelberg
Buch
Depression, Angst, traumatischer Stress und internistische Erkrankungen

Print ISBN: 978-3-662-65872-7

Electronic ISBN: 978-3-662-65873-4

Copyright-Jahr: 2022

DOI
https://doi.org/10.1007/978-3-662-65873-4_4

Neu im Fachgebiet Psychiatrie

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

23.04.2024 Depression antepartal oder postpartal Nachrichten

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

„Psychotherapie ist auch bei sehr alten Menschen hochwirksam!“

22.04.2024 DGIM 2024 Kongressbericht

Die Kombination aus Medikamenten und Psychotherapie gilt als effektivster Ansatz bei Depressionen. Das ist bei betagten Menschen nicht anders, trotz Besonderheiten.

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

22.04.2024 DGIM 2024 Nachrichten

Um Menschen nach der Flucht aus einem Krisengebiet bestmöglich medizinisch betreuen zu können, ist es gut zu wissen, welche Erkrankungen im jeweiligen Herkunftsland häufig sind. Dabei hilft eine Internetseite der CDC (Centers for Disease Control and Prevention).

Bildnachweise